An international problem needs an international solution – that is exactly how our global problems - including drug & medical products – have to be addressed.
As part of information sharing with fellow colleagues in the Retail Chapter, we highlight 2 potential product-related abuse or diversion for the information & surveillance by pharmacists, especially colleagues who work at community settings.
1) Ethylchloride-containing Products
Check out the following events and notice. Do take note and mark them on your calendar. Thanks very much.
Safety Advisory on Exenatide (ByettaTM)
US FDA notified healthcare professionals of revisions to the prescribing information for Byetta (exenatide) to include information on post-marketing reports of altered kidney function, including acute renal failure and insufficiency.
Here are 3 brief news for your quick update:
• Novartis to Pump US$1b R&D Investment in China
• Singapore to Receive US$75m R&D Investment from Abbott
• H1N1 Pandemic Fear Helps OTC Medicine Sales
The following jobs/events are currently available. Kindly apply/register directly based on the information provided. Best of luck!
• Pharmacist (Part-time / Full time) – West Point Hospital
